Picture of Universal Ibogaine logo

IBO Universal Ibogaine Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Universal Ibogaine, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.

2022
July 31st
2023
July 31st
2024
July 31st
Period Length:
Source:ARSARSARS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments0.7260.3130.371
Net Total Accounts Receivable
Net Total Receivables0.2310.0760.194
Prepaid Expenses
Total Other Current Assets
Total Current Assets1.020.4431.04
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment5.33.663.47
Other Long Term Assets
Total Assets6.325.54.51
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities2.192.790.998
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities2.373.753.52
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity3.941.750.991
Total Liabilities & Shareholders' Equity6.325.54.51
Total Common Shares Outstanding